Bank of Montreal
ONC

Bank of Montreal’s BeOne Medicines Ltd ONC Stock Holding History

Bank of Montreal’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Sell
8,145
-241
-3% -$78K ﹤0.01% 1579
2025
Q4 		$2.55M Buy
8,386
+436
+5% +$143K ﹤0.01% 1565
2025
Q3 		$2.71M Sell
7,950
-31
-0.4% -$9.41K ﹤0.01% 1530
2025
Q2 		$1.93M Buy
7,981
+5
+0.1% +$1.23K ﹤0.01% 1594
2025
Q1 		$2.17M Buy
7,976
+75
+0.9% +$17.5K ﹤0.01% 1475
2024
Q4 		$1.46M Sell
7,901
-328
-4% -$67K ﹤0.01% 1692
2024
Q3 		$1.8M Sell
8,229
-1,802
-18% -$324K ﹤0.01% 1745
2024
Q2 		$1.64M Buy
10,031
+15
+0.1% +$2.31K ﹤0.01% 1757
2024
Q1 		$1.57M Buy
10,016
+1,838
+22% +$296K ﹤0.01% 1767
2023
Q4 		$1.51M Sell
8,178
-655
-7% -$118K ﹤0.01% 1834
2023
Q3 		$1.86M Sell
8,833
-3,587
-29% -$710K ﹤0.01% 1739
2023
Q2 		$2.49M Sell
12,420
-793
-6% -$183K ﹤0.01% 1690
2023
Q1 		$2.97M Buy
13,213
+173
+1% +$41.5K ﹤0.01% 1486
2022
Q4 		$2.94M Sell
13,040
-43,435
-77% -$7.97M ﹤0.01% 1598
2022
Q3 		$7.98K Sell
56,475
-23,587
-29% -$4.05M ﹤0.01% 1103
2022
Q2 		$13.7K Buy
80,062
+65,491
+449% +$10.2M 0.01% 917
2022
Q1 		$3M Buy
14,571
+2,396
+20% +$509K ﹤0.01% 1709
2021
Q4 		$3.37M Sell
12,175
-10,406
-46% -$3.51M ﹤0.01% 1373
2021
Q3 		$8.23M Buy
22,581
+2,617
+13% +$856K ﹤0.01% 1399
2021
Q2 		$7.25M Buy
19,964
+2,868
+17% +$950K ﹤0.01% 1426
2021
Q1 		$5.38M Sell
17,096
-784
-4% -$260K ﹤0.01% 1307
2020
Q4 		$4.99M Buy
17,880
+1,819
+11% +$501K ﹤0.01% 1389
2020
Q3 		$4.75M Buy
16,061
+1,970
+14% +$463K ﹤0.01% 1232
2020
Q2 		$2.82M Buy
14,091
+2,998
+27% +$488K ﹤0.01% 1460
2020
Q1 		$1.51M Sell
11,093
-2,433
-18% -$380K ﹤0.01% 1547
2019
Q4 		$2.24M Buy
13,526
+1,426
+12% +$237K ﹤0.01% 1821
2019
Q3 		$1.48M Sell
12,100
-1,095
-8% -$145K ﹤0.01% 1873
2019
Q2 		$1.64M Sell
13,195
-1,343
-9% -$170K ﹤0.01% 1812
2019
Q1 		$1.92M Buy
14,538
+1,674
+13% +$226K ﹤0.01% 1702
2018
Q4 		$1.8M Sell
12,864
-66,320
-84% -$8.79M ﹤0.01% 1573
2018
Q3 		$13.6M Buy
79,184
+64,591
+443% +$10.9M 0.01% 797
2018
Q2 		$2.24M Buy
14,593
+1,814
+14% +$324K ﹤0.01% 1592
2018
Q1 		$2.15M Sell
12,779
-3,407
-21% -$461K ﹤0.01% 1529
2017
Q4 		$1.58M Buy
16,186
+600
+4% +$54.9K ﹤0.01% 1713
2017
Q3 		$1.61M Sell
15,586
-3,024
-16% -$225K ﹤0.01% 1729
2017
Q2 		$837K Buy
18,610
+14,128
+315% +$557K ﹤0.01% 2061
2017
Q1 		$164K Sell
4,482
-1,362
-23% -$49.6K ﹤0.01% 2583
2016
Q4 		$185K Sell
5,844
-576
-9% -$18.1K ﹤0.01% 2529
2016
Q3 		$198K Buy
6,420
+10
+0.2% +$290 ﹤0.01% 2465
2016
Q2 		$191K Buy
+6,410
New +$188K ﹤0.01% 2491

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of Montreal's ONC Position: Q1 2026 in Review

Bank of Montreal reduced its BeOne Medicines Ltd (ONC) stake by 2.9% in Q1 2026, selling an estimated $78K and leaving 8,145 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

Bank of Montreal first reported a position in ONC in Q2 2016 and has held it in 40 quarters since. The position peaked at $13.6M in Q3 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Bank of Montreal held 8,145 shares of BeOne Medicines Ltd worth $2.42M as of Q1 2026.
  • Bank of Montreal sold 241 BeOne Medicines Ltd shares in Q1 2026, an estimated $78K.
  • BeOne Medicines Ltd made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1579 holding.
  • Bank of Montreal first reported a position in BeOne Medicines Ltd in Q2 2016 and has held it in 40 quarters since.
  • Bank of Montreal's BeOne Medicines Ltd position peaked at $13.6M in Q3 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.